Hughes D C, Johnson M A, Fischer A B. "Method for the Synthesis of 4-Isopropoxy-2-(piperazin-1-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine oxalate" [P]. US Patent, US 11785153 B2, 2022-01-24.
Brown S R, Hughes D C, Chen K W. "A Process for Preparing High-Purity 4-Isopropoxy-2-(piperazin-1-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine oxalate" [P]. US Patent, US 9146958 B2, 2020-12-12.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2010, 685, (10), 7590-7595.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2010, 520, 3016-3046.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 4-Isopropoxy-2-(piperazin-1-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine oxalate Using HRMS and NMR". Sci. Total Environ., 2016, 1811, (7), 6075-6078.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2022, 1433, (4), 1353-1372.